title: Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.
abstract: The aim of this article was to perform a systematic review on the role of melatonin in the prevention of cancer tumorigenesis--in vivo and in vitro--as well as in the management of cancer correlates, such as sleep-wake and mood disturbances. The International Agency for Research on Cancer recently classified "shift-work that involves circadian disruption" as "probably carcinogenic to humans" (Group 2A) based on "limited evidence in humans for the carcinogenicity of shift-work that involves night-work", and "sufficient evidence in experimental animals for the carcinogenicity of light during the daily dark period (biological night)". The clinical implications and the potential uses of melatonin in terms of biologic clock influence (e.g. sleep and mood), immune function, cancer initiation and growth, as well as the correlation between melatonin levels and cancer risk, are hereinafter recorded and summarized. Additionally, this paper includes a description of the newly discovered effects that melatonin has on the management of sleep-wake and mood disturbances as well as with regard to cancer patients' life quality. In cancer patients depression and insomnia are frequent and serious comorbid conditions which definitely require a special attention. The data presented in this review encourage the performance of new clinical trials to investigate the possible use of melatonin in cancer patients suffering from sleep-wake and mood disturbances, also considering that melatonin registered a low toxicity in cancer patients.
authors.affiliation: Section of Human Nutrition, Health Sciences Department, Azienda di Servizi alla Persona, University of Pavia, Pavia, Italy, mariangela.rondanelli@unipv.it.
authors.forename: Mariangela
authors.initials: M
authors.lastname: Rondanelli
authors.forename: Milena Anna
authors.initials: MA
authors.lastname: Faliva
authors.forename: Simone
authors.initials: S
authors.lastname: Perna
authors.forename: Neldo
authors.initials: N
authors.lastname: Antoniello
mesh_terms: D000818:Animals; D063646:Carcinogenesis / Q000378:metabolism*; D006801:Humans; D008550:Melatonin / Q000378:metabolism*; D019964:Mood Disorders / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism* / Q000517:prevention & control*; D020178:Sleep Disorders, Circadian Rhythm / Q000378:metabolism*
chemical_list: D008550:Melatonin
references.citation: CNS Neurosci Ther. 2011 Dec;17(6):733-41
references.pmid: 21554566
references.citation: Br J Cancer. 1995 Apr;71(4):854-6
references.pmid: 7710954
references.citation: Pathol Biol (Paris). 2007 Apr-May;55(3-4):198-200
references.pmid: 17451889
references.citation: Soc Sci Med. 2002 May;54(9):1309-21
references.pmid: 12058848
references.citation: Support Care Cancer. 2002 Mar;10(2):110-6
references.pmid: 11862501
references.citation: Curr Opin Investig Drugs. 2006 May;7(5):423-31
references.pmid: 16729718
references.citation: BMJ Open. 2012 Jan 11;2(1):e000647
references.pmid: 22240653
references.citation: Am J Psychiatry. 1998 Aug;155(8):1119-21
references.pmid: 9699707
references.citation: Endocrine. 2005 Jul;27(2):119-30
references.pmid: 16217125
references.citation: J Pineal Res. 2009 Jan;46(1):1-7
references.pmid: 18761566
references.citation: J Affect Disord. 2011 Jun;131(1-3):1-7
references.pmid: 20732716
references.citation: J Biol Rhythms. 1997 Dec;12(6):644-50
references.pmid: 9406040
references.citation: Epidemiology. 2006 Jan;17(1):108-11
references.pmid: 16357603
references.citation: J Clin Oncol. 2001 Feb 1;19(3):895-908
references.pmid: 11157043
references.citation: Science. 1982 May 28;216(4549):1003-5
references.pmid: 7079745
references.citation: Breast Cancer Res Treat. 2009 May;115(1):13-27
references.pmid: 18592373
references.citation: Int J Cancer. 2006 Jan 15;118(2):274-8
references.pmid: 16080194
references.citation: Oncol Rep. 1995 Sep;2(5):871-3
references.pmid: 21597833
references.citation: J Clin Oncol. 2003 Dec 15;21(24):4635-41
references.pmid: 14673053
references.citation: J Clin Psychiatry. 2006 Feb;67(2):288-96
references.pmid: 16566626
references.citation: J Natl Cancer Inst Monogr. 2004;(32):57-71
references.pmid: 15263042
references.citation: J Pineal Res. 1990;8(3):269-76
references.pmid: 2380908
references.citation: Lancet Oncol. 2007 Dec;8(12):1065-6
references.pmid: 19271347
references.citation: Qual Life Res. 2004 Dec;13(10):1699-706
references.pmid: 15651540
references.citation: Psychooncology. 2008 Jan;17(1):9-18
references.pmid: 17428006
references.citation: Cancer Causes Control. 2012 Apr;23(4):547-53
references.pmid: 22362059
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):729-37
references.pmid: 20200429
references.citation: J Pain Symptom Manage. 2010 Mar;39(3):535-47
references.pmid: 20083371
references.citation: Expert Opin Investig Drugs. 2001 Mar;10(3):467-76
references.pmid: 11227046
references.citation: Neuro Endocrinol Lett. 2001;22(1):45-7
references.pmid: 11335879
references.citation: Breast Cancer Res Treat. 2005 Feb;89(3):243-9
references.pmid: 15754122
references.citation: Oncology. 1995 May-Jun;52(3):243-5
references.pmid: 7715908
references.citation: J Biol Rhythms. 1993 Fall;8(3):199-209
references.pmid: 8280909
references.citation: Brain Res Bull. 2010 Mar 16;81(4-5):362-71
references.pmid: 20005925
references.citation: Aging Clin Exp Res. 2009 Feb;21(1):38-42
references.pmid: 19225268
references.citation: FASEB J. 1999 May;13(8):857-68
references.pmid: 10224229
references.citation: Cancer Chemother Pharmacol. 2012 May;69(5):1213-20
references.pmid: 22271210
references.citation: Nihon Rinsho. 2001 Aug;59(8):1583-7
references.pmid: 11519164
references.citation: Curr Med Chem. 2010;17(19):2070-95
references.pmid: 20423309
references.citation: Life Sci. 1999;65(4):415-20
references.pmid: 10421427
references.citation: Eur Urol. 1997;31(2):178-81
references.pmid: 9076462
references.citation: J Pineal Res. 2005 Nov;39(4):360-6
references.pmid: 16207291
references.citation: Cancer Causes Control. 2006 May;17(4):501-7
references.pmid: 16596303
references.citation: J Pineal Res. 2008 Aug;45(1):86-92
references.pmid: 18298468
references.citation: Cancer. 1991 Mar 15;67(6):1681-4
references.pmid: 2001558
references.citation: Front Neuroendocrinol. 2000 Apr;21(2):133-70
references.pmid: 10764528
references.citation: Psychiatry Clin Neurosci. 2001 Jun;55(3):299-300
references.pmid: 11422882
references.citation: Oncology. 1990;47(5):401-5
references.pmid: 2216295
references.citation: Acta Oncol. 2009;48(4):532-40
references.pmid: 19096948
references.citation: Cancer. 1989 Jul 15;64(2):426-33
references.pmid: 2736489
references.citation: Dig Dis Sci. 2002 Oct;47(10):2336-48
references.pmid: 12395907
references.citation: Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):112-26
references.pmid: 18291293
references.citation: Melanoma Res. 2001 Apr;11(2):197-201
references.pmid: 11333131
references.citation: J Pineal Res. 2006 May;40(4):332-42
references.pmid: 16635021
references.citation: J Natl Cancer Inst. 2004 Mar 17;96(6):475-82
references.pmid: 15026473
references.citation: Breast Cancer Res Treat. 2008 Nov;112(1):197-201
references.pmid: 18064563
references.citation: Neuro Endocrinol Lett. 2002 Jul;23 Suppl 2:61-70
references.pmid: 12163851
references.citation: Cancer Causes Control. 2006 Feb;17(1):39-44
references.pmid: 16411051
references.citation: Crit Rev Oncog. 2007 Dec;13(4):303-28
references.pmid: 18540832
references.citation: J Am Geriatr Soc. 2011 Jan;59(1):82-90
references.pmid: 21226679
references.citation: Eur J Cancer. 2005 Sep;41(13):2023-32
references.pmid: 16084719
references.citation: CNS Drugs. 2009;23 Suppl 2:3-13
references.pmid: 19708721
references.citation: J Neural Transm. 1981;52(4):281-94
references.pmid: 6801199
references.citation: J Pineal Res. 2003 Aug;35(1):12-5
references.pmid: 12823608
references.citation: J Pineal Res. 2003 Oct;35(3):204-11
references.pmid: 12932205
references.citation: J Natl Cancer Inst. 2005 Jul 20;97(14):1084-7
references.pmid: 16030307
references.citation: Cancer Res. 2006 Oct 15;66(20):9789-93
references.pmid: 17047036
references.citation: Lancet. 2007 Sep 8;370(9590):851-8
references.pmid: 17826170
references.citation: Eur J Anaesthesiol. 2004 Jul;21(7):553-7
references.pmid: 15318468
references.citation: N Engl J Med. 1997 Jan 16;336(3):186-95
references.pmid: 8988899
references.citation: Cancer Res. 1998 Oct 1;58(19):4383-90
references.pmid: 9766668
references.citation: Oncology. 1996 Jan-Feb;53(1):43-6
references.pmid: 8570130
references.citation: J Biol Chem. 2004 Sep 10;279(37):38294-302
references.pmid: 15229223
references.citation: J Natl Cancer Inst. 2001 Oct 17;93(20):1563-8
references.pmid: 11604480
references.citation: Sleep. 2001 Aug 1;24(5):583-90
references.pmid: 11480655
references.citation: Chronobiol Int. 2006;23(1-2):403-12
references.pmid: 16687313
references.citation: BMJ. 2005 Mar 26;330(7493):702
references.pmid: 15695497
references.citation: J Clin Oncol. 2002 May 15;20(10):2575-601
references.pmid: 12011138
references.citation: Sleep. 2007 Nov;30(11):1460-83
references.pmid: 18041480
references.citation: Curr Treat Options Neurol. 2007 Sep;9(5):337-46
references.pmid: 17716597
references.citation: Br J Anaesth. 1999 Jun;82(6):875-80
references.pmid: 10562782
references.citation: Psychiatry Res. 2009 Feb 28;165(3):201-14
references.pmid: 19181389
references.citation: J Natl Cancer Inst. 2001 Oct 17;93(20):1513-5
references.pmid: 11604468
references.citation: Curr Top Med Chem. 2002 Feb;2(2):181-97
references.pmid: 11899100
references.citation: Clin Chim Acta. 1992 Aug 31;209(3):153-67
references.pmid: 1395046
references.citation: Cancer Lett. 2008 Sep 18;268(2):272-7
references.pmid: 18479810
references.citation: J Clin Oncol. 2011 Feb 1;29(4):413-20
references.pmid: 21149651
references.citation: Cancer Detect Prev. 2006;30(2):118-28
references.pmid: 16647824
references.citation: Sleep Med. 2010 Feb;11(2):131-6
references.pmid: 20044310
references.citation: J Clin Oncol. 1985 Jul;3(7):941-8
references.pmid: 4020407
references.citation: Anesth Analg. 2007 Nov;105(5):1263-71, table of contents
references.pmid: 17959953
references.citation: FASEB J. 2003 Apr;17(6):755-7
references.pmid: 12594180
references.citation: Am J Epidemiol. 2006 Aug 15;164(4):358-66
references.pmid: 16777931
references.citation: J Pineal Res. 2007 Nov;43(4):404-9
references.pmid: 17910609
references.citation: Carcinogenesis. 2008 Jun;29(6):1244-8
references.pmid: 18448486
references.citation: J Pineal Res. 2008 Nov;45(4):532-40
references.pmid: 19012662
references.citation: Sleep Med Rev. 2005 Feb;9(1):11-24
references.pmid: 15649735
references.citation: J Clin Psychiatry. 1990 Jun;51 Suppl:3-11; discussion 12-4
references.pmid: 2189874
references.citation: Cancer Res. 1981 Nov;41(11 Pt 1):4432-6
references.pmid: 6796259
references.citation: J Sleep Res. 2006 Sep;15(3):241-9
references.pmid: 16911025
references.citation: Oncology. 1990;47(3):275-7
references.pmid: 2342769
references.citation: J Pineal Res. 1997 Mar;22(2):86-94
references.pmid: 9181520
references.citation: Clin Evid. 2002 Jun;(7):867-82
references.pmid: 12230711
references.citation: J Pineal Res. 1997 Aug;23(1):15-9
references.pmid: 9379341
references.citation: Eur J Cancer Clin Oncol. 1987 Jul;23(7):949-57
references.pmid: 3666000
references.citation: Int J Cancer. 2013 Feb 15;132(4):891-6
references.pmid: 22644618
references.citation: Eur J Cancer. 1994;30A(2):167-70
references.pmid: 8155391
references.citation: Cancer Res. 2006 May 15;66(10):5521-5
references.pmid: 16707482
references.citation: Eur J Cancer. 1999 Nov;35(12):1688-92
references.pmid: 10674014
references.citation: Scand J Work Environ Health. 2010 Mar;36(2):163-79
references.pmid: 20126969
references.citation: Clin Cornerstone. 2004;6 Suppl 1D:S6-14
references.pmid: 15675652
references.citation: World J Biol Psychiatry. 2006;7(3):138-51
references.pmid: 16861139
references.citation: Sleep Med. 2006 Mar;7(2):123-30
references.pmid: 16459140
references.citation: Support Care Cancer. 1997 Mar;5(2):126-9
references.pmid: 9069612
references.citation: Expert Rev Mol Med. 2009 Feb 05;11:e5
references.pmid: 19193248
references.citation: Rev Reprod. 1998 Jan;3(1):13-22
references.pmid: 9509985
references.citation: Int Clin Psychopharmacol. 2010 May;25(3):132-42
references.pmid: 20195158
references.citation: Oncology (Williston Park). 2004 Jul;18(8):1021-34; discussion 1035-6, 1047-8
references.pmid: 15328896
references.citation: Cancer Res. 2005 Oct 15;65(20):9595-600
references.pmid: 16230426
references.citation: J Pineal Res. 2006 Nov;41(4):297-305
references.pmid: 17014686
references.citation: Oncol Rep. 2012 Aug;28(2):418-28
references.pmid: 22664950
references.citation: Am J Hypertens. 2005 Dec;18(12 Pt 1):1614-8
references.pmid: 16364834
references.citation: J Pineal Res. 2004 Oct;37(3):213-4
references.pmid: 15357667
references.citation: Anticancer Res. 2003 Mar-Apr;23(2C):1951-4
references.pmid: 12820485
references.citation: J Natl Cancer Inst. 2001 Oct 17;93(20):1557-62
references.pmid: 11604479
references.citation: J Pineal Res. 1997 Sep;23(2):53-8
references.pmid: 9392442
references.citation: Nutr Neurosci. 2012 Mar;15(2):46-54
references.pmid: 22334085
references.citation: J Pineal Res. 2005 May;38(4):217-22
references.pmid: 15813897
references.citation: J Natl Cancer Inst. 2008 Jun 18;100(12):898-905
references.pmid: 18544743
references.citation: Cancer. 1994 Feb 1;73(3):699-701
references.pmid: 8299092
references.citation: Psychiatry Res. 1998 Jan 16;77(1):57-61
references.pmid: 10710176
references.citation: Support Care Cancer. 2012 Jun;20(6):1203-10
references.pmid: 21637975